Document Detail

Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
MedLine Citation:
PMID:  2899439     Owner:  NLM     Status:  MEDLINE    
Celiprolol (400 mg) and atenolol (100 mg) were given once a day to 16 patients with stable angina pectoris in a double blind placebo controlled crossover study. Celiprolol produced less suppression of heart rate both at rest and during exercise than atenolol. Both drugs were equally effective in reducing the frequency of angina and in delaying the onset of ischaemia during exercise. Radionuclide ventriculography showed that atenolol but not celiprolol lowered cardiac output at rest and during exercise. Thus the ancillary properties of celiprolol, including partial beta 2 agonist activity and direct vasodilating activity, have detectable effects on cardiac function that may be beneficial in patients with angina.
J M McLenachan; J T Wilson; H J Dargie
Related Documents :
6411479 - Effect of nitroglycerin ointment (nitrong) on exercise tolerance and several circulator...
7317899 - The dose-response effects of nifedipine of st-segment changes in exercise testing: prel...
11770869 - Effect of sildenafil citrate upon myocardial ischemia in patients with chronic stable a...
3883739 - Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifed...
2574729 - The efficacy and safety of dilevalol in patients with chronic stable angina pectoris.
2883869 - Systemic and coronary hemodynamic effects of combined alpha- and beta-adrenergic blocka...
20446069 - Electrical muscle stimulation for chronic heart failure: an alternative tool for exerci...
3977809 - Effect of physical training in cool and hot environments on +gz acceleration tolerance ...
1986689 - Reductions in exercise lactic acidosis and ventilation as a result of exercise training...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British heart journal     Volume:  59     ISSN:  0007-0769     ISO Abbreviation:  Br Heart J     Publication Date:  1988 Jun 
Date Detail:
Created Date:  1988-09-02     Completed Date:  1988-09-02     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0370634     Medline TA:  Br Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  685-9     Citation Subset:  AIM; IM    
Department of Cardiology, Western Infirmary, Glasgow.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use*
Angina Pectoris / drug therapy*,  physiopathology
Atenolol / therapeutic use*
Blood Pressure / drug effects
Clinical Trials as Topic
Depression, Chemical
Double-Blind Method
Heart Rate / drug effects
Hemodynamics / drug effects
Middle Aged
Physical Exertion
Propanolamines / therapeutic use*
Random Allocation
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Propanolamines; 29122-68-7/Atenolol; 56980-93-9/Celiprolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  In vitro susceptibility of diarrhoea producing gram negative enteric bacteria to sulfasalazine, 5-am...
Next Document:  Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon.